BGPT: Author Review: Yigong Shi

Explore by Goal

Quick Explanation Copied

Yigong Shi appears to have a research profile dominated by mechanistic structural biology of signaling and cell-death pathways (e.g., PP2A–Tau targeting; caspase/IAP machinery; spliceosome/gamma-secretase/NPC themes), with strong bibliometric impact (very high citation counts and h-index from OpenAlex data you provided).

Most evidence-backed strengths from the included paper extracts:

High-quality structural mechanistic** claims grounded in X-ray crystallography with deposited coordinates (PDB) for a PP2A holoenzyme–Tau targeting model (see figure).
Mechanistic apoptosis-regulation work including structural interfaces for DIAP1–Hid/Grim using crystallography, consistent with a structural-biology approach to regulatory specificity.
Broad theme alignment with caspase regulation, though review-format evidence is inherently syntheses rather than new data in the provided extracts.

Long Explanation

Author Review: Yigong Shi

Science focus: Structural/mechanistic cell biology

Evidence-based critique using only the information contained in your provided paper extracts and bibliometric snippets. Because you provided a very large list of titles without DOIs for each, the in-depth evidence below is constrained to the explicitly provided DOI-based extracts (https://dx.doi.org/10.1016/j.molcel.2008.08.006–https://dx.doi.org/10.7554/elife.03678) and the OpenAlex bibliometrics you supplied.

1) Evidence-grounded scientific strengths (from provided extracts)

PP2A holoenzyme → Tau dephosphorylation: structural targeting model

The extract describes an in vitro fully recombinant reconstitution of Tau dephosphorylation by a B55-containing PP2A holoenzyme, combined with a crystal structure of the holoenzyme and mutational tests of a proposed Tau-binding groove.
The extract further reports a measured Tau–Ba binding affinity scale (~mM range) and explicitly flags physiological-relevance uncertainty.

DIAP1–Hid/Grim: structural basis for apoptosis inhibition specificity

The extract describes crystallographic complexes of a DIAP1 fragment (BIR2) with Grim and Hid peptides, with peptide-induced conformational changes that enhance interaction.
The extract explicitly cautions about limited in vivo representativeness for an in vitro/crystallization context.

A mechanistic metabolic link: ERAB/L-3-HADH-II and Aβ cytotoxicity

The extract reports cell-line transfection experiments (COS-1 and neuroblastoma) and indicates enzymatic activity is necessary for full Aβ cytotoxicity effects, linking metabolism to pathology.
The extract flags cell-line generalizability as a blind spot.

2) Visual evidence: what the PP2A holoenzyme extract supports (and where it is fragile)

Skeptical interpretation checklist

Structural plausibility: the extract states Ba is a seven-bladed WD40 propeller engaging A subunit HEAT repeats with a central acidic groove implicated in substrate targeting.
Biochemical coupling: the extract reports that Ba-containing holoenzyme enhances Tau dephosphorylation compared with core enzyme, and that Ba mutants disrupting the groove reduce dephosphorylation.
Physiological relevance risk: reported Tau–Ba affinity is weak (approx. 3 mM) and the extract flags this as a concern for in vivo relevance.
Crystallographic uncertainty: the extract notes disordered regions in the model and possible crystallization-condition effects (e.g., microcystin-LR incubation for holoenzyme crystal formation).

3) Field-relevance map: what this suggests about author research style

This “style map” is not a claim about the full publication record—only a visual summary of the themes explicitly present in the provided extracts: PP2A substrate targeting via holoenzyme reconstitution + structure (), DIAP1 apoptosis regulation via peptide-induced conformations observed in crystal structures (), a cell-line metabolic-to-pathology link for Aβ cytotoxicity (), and a review synthesis on caspase regulation ().

4) Evidence density by provided extract (quality-style scores + what they mean)

Critical note on interpretation: these scores are the rubric outputs you provided, not an independent metric from BGPT. They are useful for comparing within your dataset, but they do not replace reading the original studies.

5) Main blind spots / counterpoints (based only on the extracts)

In vitro reconstitution vs cellular physiology: even when structural and biochemical coupling is strong, binding affinities and targeting mechanisms may not translate cleanly to cellular contexts; the PP2A–Tau extract flags weak (~mM) binding as a specific concern.
Crystallization-context sensitivity: any structural mechanism inferred from crystal conformations can be impacted by construct design and cofactor/incubation conditions; the PP2A holoenzyme workflow includes microcystin-LR incubation and the extract notes disordered segments.
Cell-line limitations: the ERAB/HADH-II ↔ Aβ cytotoxicity extract relies on specific cell lines and transfection/overexpression paradigms; this can skew pathway behavior relative to native tissue physiology.
Review-format evidence is aggregation: the caspase regulation paper is a review in the provided extract; interpret it as synthesis rather than direct experimental validation.

What would most disprove/reshape the extracted PP2A mechanism?

Demonstrating that Ba does not enhance Tau dephosphorylation in matched contexts, or that the proposed groove/tau segments do not causally contribute under more physiological conditions.

User-facing take

From the provided extracts, the most defensible conclusion is that Shi’s work (at least in these examples) emphasizes mechanistic structural biology paired with biochemical functional coupling, while also acknowledging limitations like weak binding affinities, disordered regions, and context dependence.

Feedback:

Updated: March 22, 2026